Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J, Fan W, Li Y, Tang R, Tian C, Yang Q, Zhu T, Diao C, Hu S, Chen M, Guo P, Long Q, Zhang C, Qin G, Yu W, Chen M, Li L, Qin L, Wang J, Zhang X, Ren Y, Zhou P, Zou L, Jiang K, Guo W, Deng W.
Hao J, et al. Among authors: li y, li l.
J Exp Clin Cancer Res. 2019 Feb 4;38(1):48. doi: 10.1186/s13046-019-1036-z.
J Exp Clin Cancer Res. 2019.
PMID: 30717768
Free PMC article.